Vimal Mehta
2023
In 2023, Vimal Mehta earned a total compensation of $4.7M as Chief Executive Officer at BioXcel Therapeutics, a 4% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,615,928 |
|---|---|
| Salary | $1,001,569 |
| Stock Awards | $1,097,600 |
| Other | $16,050 |
| Total | $4,731,147 |
Mehta received $2.6M in option awards, accounting for 55% of the total pay in 2023.
Mehta also received $1M in salary, $1.1M in stock awards and $16.1K in other compensation.
Rankings
In 2023, Vimal Mehta's compensation ranked 134th out of 3,006 executives tracked by ExecPay. In other words, Mehta earned more than 95.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 134 out of 3,006 | 96th |
Division Manufacturing | 71 out of 1,650 | 96th |
Major group Chemicals And Allied Products | 43 out of 918 | 95th |
Industry group Drugs | 42 out of 881 | 95th |
Industry Pharmaceutical Preparations | 28 out of 637 | 96th |
Source: SEC filing on April 29, 2024.
Mehta's colleagues
We found two more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2023.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019